- Home
- EQV vs DNA Comparison
EQV vs DNA Comparison
Compare EQV & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQV
- DNA
- Stock Information
- Founded
- EQV 2024
- DNA 2008
- Country
- EQV United States
- DNA United States
- Employees
- EQV N/A
- DNA N/A
- Industry
- EQV
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EQV
- DNA Health Care
- Exchange
- EQV Nasdaq
- DNA Nasdaq
- Market Cap
- EQV 461.8M
- DNA 552.0M
- IPO Year
- EQV 2024
- DNA N/A
- Fundamental
- Price
- EQV $10.35
- DNA $12.54
- Analyst Decision
- EQV
- DNA Hold
- Analyst Count
- EQV 0
- DNA 2
- Target Price
- EQV N/A
- DNA $8.50
- AVG Volume (30 Days)
- EQV 120.2K
- DNA 1.5M
- Earning Date
- EQV 01-01-0001
- DNA 08-07-2025
- Dividend Yield
- EQV N/A
- DNA N/A
- EPS Growth
- EQV N/A
- DNA N/A
- EPS
- EQV N/A
- DNA N/A
- Revenue
- EQV N/A
- DNA $230,815,000.00
- Revenue This Year
- EQV N/A
- DNA N/A
- Revenue Next Year
- EQV N/A
- DNA $15.91
- P/E Ratio
- EQV $50.45
- DNA N/A
- Revenue Growth
- EQV N/A
- DNA 25.21
- 52 Week Low
- EQV $9.88
- DNA $5.00
- 52 Week High
- EQV $10.74
- DNA $16.85
- Technical
- Relative Strength Index (RSI)
- EQV 40.69
- DNA 51.34
- Support Level
- EQV $10.35
- DNA $10.96
- Resistance Level
- EQV $10.40
- DNA $14.20
- Average True Range (ATR)
- EQV 0.06
- DNA 1.20
- MACD
- EQV -0.00
- DNA -0.22
- Stochastic Oscillator
- EQV 6.71
- DNA 42.09
About EQV EQV Ventures Acquisition Corp.
EQV Ventures Acquisition Corp is a blank check company.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.